BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 9034298)

  • 1. Omalizumab for the management of refractory aquagenic pruritus.
    Koumaki D; Gregoriou S; Katoulis A; Evangelou G
    J Eur Acad Dermatol Venereol; 2023 Nov; 37(11):e1316-e1317. PubMed ID: 37415343
    [No Abstract]   [Full Text] [Related]  

  • 2. Pulmonary Hypertension in Myeloproliferative Neoplasms: New Insights and Unexplored Horizons.
    Leiva O; Garcia BD; Hobbs G
    Am J Respir Crit Care Med; 2023 Sep; 208(5):518-521. PubMed ID: 37429036
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of pruritus associated with systemic disorders in the elderly: a review of the role of new therapies.
    Lonsdale-Eccles A; Carmichael AJ
    Drugs Aging; 2003; 20(3):197-208. PubMed ID: 12578400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Danazol relieves refractory pruritus associated with myeloproliferative disorders and other diseases.
    Kolodny L; Horstman LL; Sevin BU; Brown H; Ahn YS
    Am J Hematol; 1996 Feb; 51(2):112-6. PubMed ID: 8579050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Itching of the skin in myeloproliferative disease treated with cimetidine].
    Berild D; Hasselbalch H
    Ugeskr Laeger; 1985 Apr; 147(17):1403-4. PubMed ID: 4002413
    [No Abstract]   [Full Text] [Related]  

  • 6. Omalizumab alleviates pruritus in myeloproliferative neoplasms.
    Ravn Landtblom A; Ungerstedt J; Hedlund A; Tobiasson M; Deneberg S; Jädersten M
    Haematologica; 2023 Jul; 108(7):1968-1971. PubMed ID: 36700402
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical characteristics of aquagenic pruritus in patients with myeloproliferative neoplasms.
    Le Gall-Ianotto C; Brenaut E; Gouillou M; Lacut K; Nowak E; Tempescul A; Berthou C; Ugo V; Carré JL; Misery L; Ianotto JC
    Br J Dermatol; 2017 Jan; 176(1):255-258. PubMed ID: 27291777
    [No Abstract]   [Full Text] [Related]  

  • 8. Cimetidine for the treatment of pruritus.
    Hess CE
    N Engl J Med; 1979 Feb; 300(7):370. PubMed ID: 759904
    [No Abstract]   [Full Text] [Related]  

  • 9. Danazol in refractory pruritus of myeloproliferative disorders.
    Randi ML; Luzzatto G; Fabris F
    Am J Hematol; 1997 Feb; 54(2):172-3. PubMed ID: 9034298
    [No Abstract]   [Full Text] [Related]  

  • 10. Danazol in non-splenectomized patients with refractory idiopathic thrombocytopenic purpura.
    Edelmann DZ; Knobel B; Virag I; Meytes D
    Postgrad Med J; 1990 Oct; 66(780):827-30. PubMed ID: 2099421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Danazol for paroxysmal nocturnal hemoglobinuria.
    Harrington WJ; Kolodny L; Horstman LL; Jy W; Ahn YS
    Am J Hematol; 1997 Feb; 54(2):149-54. PubMed ID: 9034290
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.